Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.080
+0.070 (2.33%)
At close: Aug 7, 2026, 4:00 PM EDT
3.070
-0.010 (-0.32%)
After-hours: Aug 7, 2026, 7:53 PM EDT
Altimmune Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Altimmune stock has a consensus rating of "Strong Buy" and an average price target of $17.22. The average 1-year stock price forecast is 459.09% higher than the current stock price, while the lowest is $11 (+257.14%) and the highest is $28 (+809.09%).
Price Target: $17.22 (+459.09%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Altimmune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 1 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 29, 2026 |
| Barclays | Barclays | Buy Maintains $20 | Buy | Maintains | $20 | +549.35% | Jul 28, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $1 → $20 | Buy | Maintains | $1 → $20 | +549.35% | Jul 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $10 | Buy | Maintains | $10 | +224.68% | Jul 28, 2026 |
Financial Forecast
Revenue This Year
n/a
from 41.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.57
from -1.00
EPS Next Year
-0.69
from -0.57
EPS and Forward PE are based on non-GAAP adjusted numbers.